Resistance, Ineffectiveness, and Off-Label Use Related to Cephalosporins from the Reserve Group—A Pharmacovigilance Signal Detection Study on EudraVigilance Database

A multicenter evaluation of patients’ knowledge of adverse drug reactions

Automating Individualized Notification of Drug Recalls to Patients: Complex Challenges and Qualitative Evaluation

Pancreatitis induced by Peg-aspargase in children: a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS)

Unveiling the Limits of Anticholinergic Burden Scales: A Study of Adverse Drug Reactions in the French Pharmacovigilance Database

Risk of drug eruption associated with the use of tetracyclines, macrolides, and fluoroquinolones: real-world evidence from a pharmacovigilance study utilizing the FDA adverse event reporting system

A Critical Analysis of the Laws Regulating the Sale of Counterfeit Goods in Cameroon

Patient perspectives on drug recalls in the Netherlands: a qualitative study

Adverse Drug Reactions in Patients With Hepatic Impairment: A Cross-Sectional Study

Integrating Pharmacogenomics into the Beers Criteria: A Machine Learning-driven Risk Assessment Framework for Novel Gene Drug Interactions

Comparative Gynecological Safety of the Dual GIP/GLP-1 Receptor Agonist Tirzepatide vs. the GLP-1 Receptor Agonist Semaglutide: A Real-World Pharmacovigilance Analysis (2022–2025)

Pharmacovigilance in the Post-COVID Era: Lessons Learned and Paradigm Shifts from the Indian Experience

Signal mining and safety profile analysis of lapatinib: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database

MHRA statement on new review of paracetamol safety during pregnancy

Public Views About Opioid Overdose and People With Opioid Use Disorder

A CROSS-SECTIONAL STUDY ON PERCEPTIONS OF PHARMACOVIGILANCE AMONG UNDERGRADUATE MEDICAL STUDENTS FROM NORTHERN INDIA

A short communication on digital and smart pharmacology: A new frontier in personalized medicine

Perception and Acceptance of Generic Medicines Among Consumers: A Comparative Qualitative Study with Branded Drug

Color anti-counterfeiting quick response code: An enhanced authentication method via dual-spectral feature analysis

The association between colorectal cancer drugs and heart failure: a real-world pharmacovigilance study of the FAERS database

Perspective on Better Access to Data and Data Integration in Pharmacovigilance: Information from a Focus Group

FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications

Electronic Intervention for Patient-Managed Benzodiazepine Tapering. Randomized Clinical Trial

Incomplete Patient Medication Histories Pose a Significant Barrier to Finding the Best Treatment Choices in Outpatient Community Care

Postmarket Safety Actions for Novel Oncology Drugs Granted FDA’s Accelerated Approval

Pharmacovigilance Knowledge, Attitudes, and Practices Among Healthcare Professionals in Nepal: A Systematic Review

Real-world safety profile of roflumilast: a pharmacovigilance analysis using FDA adverse event reporting system and Canada vigilance database

Adverse Events After Metastases-Directed Stereotactic Radiotherapy and Biological Cancer Therapy

Nimesulide-Associated Generalized Bullous Fixed Drug Eruption: A Rare Pharmacovigilance Case Report

Work Hours, Stress, and Burnout Among Resident Physicians

Millions with dementia still prescribed drugs linked to falls and confusion

EMA and FDA set common principles for AI in medicine development

Large-Scale Counterfeit Pill Manufacturer Pleads Guilty

Incumplimientos a las Buenas Prácticas de Farmacovigilancia por parte de la firma BIOTENK S.A.

Mueren dos pacientes oncológicos en el Hospital de Burgos por un error en su medicación

Updated Labeling for Menopausal Hormone Therapy

Navigating Conflicting Vaccination Recommendations. Guidance for Clinicians

ANMAT inhibe preventivamente la firma Biotenk S.A

The global Dx AMR collaborative: an approach to strengthen the role of diagnostics in combating antimicrobial resistance

Patient-Centric Pharmacovigilance in India: Innovative Approaches to Adverse Event Reporting and Risk Communication